Patent · US Active

CD137 binding fibronectin type III domains

US12258385B2 · kind B2 · utility

0Cited by

58References

9Claims

0Family size

Assignee

JANSSEN BIOTECH, INC. · US

Inventors

Michael Diem · Havertown, US
Rebecca Hawkins · Harleysville, US
Steven Jacobs · North Wales, US
Manuel Sepulveda · Princeton Junction, US

Key dates

Filing date	Apr 28, 2022
Grant date	Mar 25, 2025
Priority date	—
Expiry date	Jul 13, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/40
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

FN3 domains that specifically bind to CD137, their conjugates, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making and using them are useful in therapeutic and diagnostic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.